Novo Nordisk A/S shares rise 1.71% premarket after Data I/O Corporation's Q2 2025 earnings call.

viernes, 25 de julio de 2025, 4:03 am ET1 min de lectura
NVO--
Novo Nordisk A/S rose 1.71% in premarket trading. The company's stock price increase may be attributed to the positive news of West Pharma raising its annual profit forecast due to strong demand for its drug components.

Novo Nordisk A/S shares rise 1.71% premarket after Data I/O Corporation's Q2 2025 earnings call.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios